Pharma 4.0 Optimizing Manufacturing Operations through Digitalization
Industry 4.0, also known as Smart Industry, is becoming prevalent across various sectors, including the pharmaceutical industry. Technologies like the Internet of Things (IoT), cloud computing, and automated data exchange are now integral to the industry. This white paper explores the implications of Industry 4.0 for pharma, highlighting the benefits of adopting pharma 4.0 technologies and strategies to avoid common Challenges. It emphasizes the need for the (bio) pharmaceutical industry to produce high-quality medicines consistently. The paper introduces smart pharma technologies to achieve this, focusing on our innovation: a voice-controlled electronic Batch Record system.
The International Society for Pharmaceutical Engineering (ISPE) is advancing the adoption of Industry 4.0 in the pharmaceutical industry through the concept of pharma 4.0. The ISPE developed business cases to demonstrate the benefits and challenges of implementing automation and digitalization technologies in pharma, especially concerning health regulations. Pharma 4.0 aims to connect all aspects of digitalized plant operations, enhancing transparency, speed, decision-making, and real-time control over processes, operations, and quality. Advances in AI, IIoT, VR, cloud computing, advanced analytics, and machine-to-machine communication have significantly impacted pharmaceutical manufacturing, quality control, equipment maintenance, and supply chain documentation. However, the increased connectivity also raises security vulnerabilities, necessitating enhanced security measures in pharma 4.0.
Potential Benefits of Pharma 4.0 Technology
- Accelerate Your Operations: Technological advancements, such as tailor-made Manufacturing Execution Systems (MES) and personalized electronic Batch Record (eBR) systems, ensure precise operational control and compliance with regulations, thereby speeding up processes.
- Increase Operational Reliability: Real-time working instructions and smart sensors enhance process control and reliability. These technologies also improve the reliability of outsourced processes and reduce falsification risks using real- time remote control and RFID technology.
- Save Time and Reduce Risk: Automating batch record completion ensures complete traceability, cuts operational costs, reduces the risk of contamination, and eliminates the need for manual entry, thus saving time.
- Accelerate the Go-to-Market Process: Automatic generation of batch records, highlighting non-conformities and critical steps, speeds up and improves the medication release process.
Getting Started with Pharma 4.0
Step 1: Choose Your Investments Wisely
To successfully implement digital transformation through smart pharma technologies, it's crucial to analyze business-critical processes carefully. Identifying which processes need technological support can be challenging, leading to the risk of investing in popular but unsuitable Pharma 4.0 technologies.
Organizations often end up adapting their processes to fit new technologies instead of choosing technologies that align with and solve their specific business needs. This is particularly relevant for supply chain control and data recording processes. Companies, especially startups and those in Advanced Therapy Medicinal Products (ATMPs), must assess their true needs for optimizing processes.
The type and size of the pharmaceutical company determine which processes require attention. Small companies producing early-phase clinical trial medications have different needs than large companies manufacturing millions of drug products. Each company needs a unique approach tailored to its business objectives and expectations.
However, all (bio) pharmaceutical companies share common goals: reducing operational supply chain costs and relieving administrative burdens. Smart pharma technologies help tackle these goals effectively.
Step 2: Optimize Your Processes
Smart pharma technology focuses on processing large amounts of data to enhance the quality and efficiency of supply chain processes like manufacturing, filling, quality control, and shipping, while adhering to pharmaceutical safety regulations. It primarily controls Critical Process Parameters (CPPs) and achieves Critical Quality Attributes (CQAs) without setting them. To gain the full benefits, companies must carefully analyze and optimize their processes and pain points before adopting Pharma 4.0 technology.
Streamlining existing processes can be done through traditional quality improvement techniques or by automating repetitive tasks. Quality by design tools help set CQAs and CPPs, while risk management tools like Failure Modes and Effects Analysis (FMEA) reduce risks associated with supply chains, quality, and safety. Automating routine tasks with robots or computer programs eliminates human variability and enhances process efficiency.
Innovation of Pharma 4.0: Automating Batch Records
Pharmaceutical companies must ensure complete traceability of each drug batch for patient safety, which involves creating and completing batch records that document various aspects of production. Manual generation of Master Batch Records (MBRs) and Batch Records (BRs) is cumbersome and inefficient, requiring constant operator presence and offering no added value to medication quality.
Automation of these processes can significantly reduce costs and shorten time-to- market. Many companies still use paper-based MBRs and BRs, so transitioning to electronic Batch Records (eBRs) is the first step towards automation, offering numerous advantages. Despite the benefits of electronic Batch Records (eBRs), the aseptic manufacturing industry hesitates to adopt the technology due to regulatory requirements and a lack of real innovation. Current eBR solutions are more efficient than paper records but still fall short of customer needs, especially in aseptic processes. Operators must manually read instructions and enter data, which is time- consuming and increases the risk of human error and contamination.
SmartReg, a voice-controlled eBR bot developed by salamanderU
Addresses these issues by automating the recording process. This innovation minimizes human contact, reduces contamination risks, and enhances productivity by allowing operators to focus on their tasks without constant interruptions. SmartReg aims to ensure patient safety and optimal manufacturing traceability with minimal inconvenience for operators.
SmartReg, designed by pharmaceutical experts for the industry, is the world’s first patented, web-based electronic Batch Record (eBR) system featuring voice recognition and a voice synthesizer. This innovative system simplifies and streamlines manufacturing and recording operations by guiding operators through work processes, verifying correct execution, and alerting them to any mistakes. SmartReg records audio of the operator’s actions, eliminating the need for additional personnel to document the process, thereby allowing the operator to manage everything independently.
It goes without saying that a voice-controlled eBR retains all the advantages of other eBRs, some of which have already been mentioned above. SmartReg, however, also offers other useful attributes such as easy BR and MBR accessibility, easy MBR preparation and validation, easy BR creation and approval, as explained in the white paper.
Conclusion
Industry 4.0, or the Smart Industry, offers numerous advantages to the pharma industry, such as optimized production processes, real-time control, and reliable manufacturing. The voice-controlled electronic Batch Record system, SmartReg, reduces human error and contamination, saves time and costs, boosts productivity, and simplifies data management.
Pharma 4.0 ensures patient safety by providing clear traceability, better control, and optimized processes, enabling faster and more effective decision-making. However, each organization requires a customized approach. SalamanderU tailors solutions like SmartReg to meet specific needs and challenges and ensuring optimal process improvement.
Download '.pdf' Format of the whitepaper.
